Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
Seeking Alpha / 44 minutes from now 1 Views
clonoSEQ® is now integrated into Flatiron Health’s OncoEMR®, simplifying MRD testing access for over 4,500 clinicians across the Flatiron network.
Comments